Trikafta: How a 'Miracle' Cystic Fibrosis Drug Has Impacted a Community | Elemental

Trikafta: How a 'Miracle' Cystic Fibrosis Drug Has Impacted a Community | Elemental

What comes after the ‘miracle drug’

Last October, a treatment that promised to transform the lives of 90% of people with cystic fibrosis was approved in the United States. The three-part drug, Trikafta, has been spectacularly effective for some people, but it’s expensive, only available in the United States and is not suitable for everyone. With the promise of more precision-medicine successes on the horizon, Trikafta offers a case study of what happens after a long-awaited drug becomes a reality.

Elemental | 18 min read